Adjunctive effect of collagen membrane coverage to L-PRF in the treatment of periodontal intrabony defects: a randomized controlled clinical trial with biochemical assessment.

Autor: Mubarak R; Department of Oral Medicine, Periodontology and Diagnosis, Faculty of Oral and Dental Medicine, Future University, Cairo, Egypt. ramy.mobarak@fue.edu.eg., Adel-Khattab D; Department of Oral Medicine, Periodontology and Diagnosis, Faculty of Dentistry, Ain Shams University, Cairo, Egypt., Abdel-Ghaffar KA; Oral Medicine, Periodontology and Diagnosis, Faculty of Dentistry Ain Shams University, Cairo, Egypt., Gamal AY; Oral Medicine, Periodontology and Diagnosis, Faculty of Dentistry Ain Shams University, Cairo, Egypt.; Faculty of Dentistry, Misr University for Science and Technology, Giza, Egypt.
Jazyk: angličtina
Zdroj: BMC oral health [BMC Oral Health] 2023 Sep 04; Vol. 23 (1), pp. 631. Date of Electronic Publication: 2023 Sep 04.
DOI: 10.1186/s12903-023-03332-0
Abstrakt: Background: The innovation of leukocyte platelet-rich fibrin (L-PRF) has added enormous impact on wound healing dynamics especially the field of periodontal regeneration. The release of growth factors (GF) is thought to improve the clinical outcomes in infrabony defects. The aim of this study was to evaluate the clinical effect of covering L-PRF contained infrabony defects with collagen membranes (CM), and to compare their GF release profile to uncovered L-PRF defects and open flap debridement (OFD).
Methods: Thirty non- smoking patients with infrabony pockets participated to be randomly assigned to OFD group (n = 10), L-PRF group (n = 10), or L-PRF protected CM group (n = 10). Plaque index (PI), gingival index (GI), probing depth (PD), clinical attachment level (CAL) and the radiographic defect base fill (DBF) were measured at baseline and at 6 month following surgical intervention. Gingival crevicular fluid samples were obtained on days 1, 3, 5, 7, 14, 21 and 30 days following surgery for the Platelet Derived Growth Factor-BB (PDGF-BB) and Vascular Endothelial Growth Factors (VEGF) release profile evaluation.
Results: For all patients, a statistically significant (P ≤ 0.05) reduction in PI, GI, PD and CAL were reported throughout the study period. Differences between the three treatment modalities were not statistically significant. PRF + CM showed a statistically significant DBF compared to OFD and L-PRF groups at follow up. Quantitative analysis of PDGF-BB and VEGF levels demonstrated a statistically significant (P < 0.001) decline between measurement intervals for all groups with no statistically significant differences between the three groups.
Conclusion: Within the limitations of this study, L-PRF coverage with CM may augment defect base fill through its mechanical protective effect without enhancement in the release profile of VEGF and PDGF. The non-significant intergroup differences question the validity of the claimed extra physiologic concentration of GF offered by L-PRF harvests.
Trial Registration: The present study was registered at ClinicalTrials.gov (NCT05496608), (11/08/2022).
(© 2023. BioMed Central Ltd., part of Springer Nature.)
Databáze: MEDLINE
Externí odkaz: